Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)

BACKGROUND: Limited real-world data from routine clinical care are available on the safety and effectiveness of treatment with taliglucerase alfa in patients with Gaucher disease (GD). METHODS: Taliglucerase Alfa Surveillance (TALIAS), a multinational prospective Drug Registry of patients with GD, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Titievsky, Lina, Schuster, Tilman, Wang, Ronnie, Younus, Muhammad, Palladino, Andrew, Quazi, Kabir, Wajnrajch, Michael P., Hernandez, Betina, Becker, Pamela S., Weinreb, Neal J., Chambers, Christina, Mansfield, Roy, Taylor, Louise, Tseng, Li-Jung, Kaplan, Paige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973565/
https://www.ncbi.nlm.nih.gov/pubmed/35365177
http://dx.doi.org/10.1186/s13023-022-02289-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973565/
https://www.ncbi.nlm.nih.gov/pubmed/35365177
http://dx.doi.org/10.1186/s13023-022-02289-7

Ejemplares similares